Literature DB >> 7351814

Nonequality of brand name thyroxine preparations.

J M Jacobson, A Ramos-Gabatin, R L Young, S C Watkins, M L Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7351814     DOI： 10.1001/jama.243.8.733b

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  The emergence of levothyroxine as a treatment for hypothyroidism.

Authors:  James V Hennessey
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

2.  Thyroid hormone replacement.

Authors:  R Cygan; L Rucker
Journal:  West J Med       Date:  1983-08

3.  Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures.

Authors:  Ingeborg Walter-Sack; Christof Clanget; Reinhard Ding; Christoph Goeggelmann; Vera Hinke; Matthias Lang; Johannes Pfeilschifter; Yorki Tayrouz; Karl Wegscheider
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

4.  Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine.

Authors:  J C Ingbar; M Borges; S Iflah; R E Kleinmann; L E Braverman; S H Ingbar
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

Review 5.  A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Authors:  Philippe Colucci; Corinne Seng Yue; Murray Ducharme; Salvatore Benvenga
Journal:  Eur Endocrinol       Date:  2013-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.